Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  T2 Biosystems Inc    TTOO

T2 BIOSYSTEMS INC (TTOO)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/12/2018 02/13/2018 02/14/2018 02/15/2018 02/16/2018 Date
4.41(c) 4.44(c) 4.77(c) 4.86(c) 4.57(c) Last
111 062 92 370 162 047 130 054 139 724 Volume
+3.04% +0.68% +7.43% +1.89% -5.97% Change
More quotes
Financials ($)
Sales 2017 4,25 M
EBIT 2017 -52,4 M
Net income 2017 -59,3 M
Debt 2017 4,53 M
Yield 2017 -
Sales 2018 13,1 M
EBIT 2018 -48,7 M
Net income 2018 -58,2 M
Debt 2018 12,6 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 42,1x
EV / Sales2018 14,3x
Capitalization 174 M
More Financials
Company
T2 Biosystems, Inc. engages in the development of innovative and proprietary technology platform.It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood,... 
More about the company
Surperformance© ratings of T2 Biosystems Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on T2 BIOSYSTEMS INC
02/15T2 BIOSYSTEMS : Blood test cuts time to diagnosis for common, deadly yeast infec..
AQ
02/09Two New Studies Demonstrate T2Candida’s Advantages over Current Diagnos..
GL
02/09T2 BIOSYSTEMS : Blood Test Cuts Time to Diagnosis for Common, Deadly Yeast Infec..
AQ
02/09BIOCENTURY - MANAGEMENT TRACKS : Arcturus, Kymera
AQ
02/06T2 Biosystems to Present at the 7th Annual Leerink Partners Global Healthcare..
GL
02/05T2 Biosystems Announces CFO Transition
GL
02/05T2 BIOSYSTEMS, INC. : Change in Directors or Principal Officers, Financial State..
AQ
01/08T2 BIOSYSTEMS, INC. : Results of Operations and Financial Condition, Financial S..
AQ
01/04T2 Biosystems Announces Preliminary Fourth Quarter 2017 Financial Results and..
GL
2017T2 BIOSYSTEMS,INC. (NASDAQ : TTOO) Files An 8-K Entry into a Material Definitive..
AQ
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
02/15STRYKER : U.S. Regulators Extend Window for Critical Stroke Treatment
DJ
02/15STRAUMANN : margin outlook takes shine off revenue surge
RE
02/15COLOPLAST A/S : ConvaTec beats low full-year expectations, shares rise
RE
02/07ESSILOR INTERNATIONAL : Makes Changes to Board of Directors
DJ
02/06BECTON DICKINSON AND : Revenue Helped by Life-Sciences -- Earnings Review
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
02/14John McDonough, Head of Distribution and Marketing, on future proofing the as.. 
02/13If you had deposed John McDonough from the Obama WH, or Josh Bolton from the ..
37
02/13T2 Biosystems $TTOO Given a $8.00 Price Target at HC Wainwright  
02/12T2 Biosystems $TTOO Given Daily News Impact Rating of 0.11  
02/11$TTOO - T2 Biosystems Inc #TTOO Expected to Announce Quarterly Sales of $1.20.. 
More tweets
Qtime:58
News from SeekingAlpha
02/09T2 Biosystems Is Transforming The Treatment Of Sepsis 
02/05T2 Bio finance chief bids adieu 
01/29Premarket analyst action - healthcare 
01/19U.S. BIOTECH/PHARMA SECTOR DAILY OBS : Jan. 18, 2018 
2017BIOTECH FORUM DAILY DIGEST : What Now For Recro Pharma? 
Chart T2 BIOSYSTEMS INC
Duration : Period :
T2 Biosystems Inc Technical Analysis Chart | TTOO | US89853L1044 | 4-Traders
Technical analysis trends T2 BIOSYSTEMS INC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 5,64 $
Spread / Average Target 16%
EPS Revisions
Managers
NameTitle
John P. McDonough President, Chief Executive Officer & Director
Joanne Spadoro Chief Operating Officer
John M. Sprague Chief Financial Officer
Thomas Jay Lowery Chief Scientific Officer
Michael A. Pfaller Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
T2 BIOSYSTEMS INC15.78%171
MEDTRONIC PLC1.37%110 797
BAXTER INTERNATIONAL2.15%35 975
ZIMMER BIOMET HOLDINGS-2.46%23 831
TERUMO CORP2.42%19 820
ALIGN TECHNOLOGY10.87%19 751